Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025
-
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
-
T-knife Therapeutics Announces Four Upcoming Data Presentations on PRAME-Targeted TK-6302 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
-
Kojamo plc’s Interim Report 1 January–30 September 2025
-
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025
-
Harvia will publish its Interim report for January–September 2025 on Thursday, 6 November 2025 at around 9:00 a.m. EET
-
Municipality Finance will redeem early notes issued under its MTN programme
-
Evaxion raises $7.2 million, extending cash runway to second half of 2027
-
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
-
Ramsey Theory Group CEO Dan Herbatschek Urges Enterprises to Prepare for Post-SaaS Era as AI Agents Reshape Software Delivery and Licensing Models
-
Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
-
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Rα Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
-
First National Corporation Reports Record Third Quarter 2025 Earnings
-
Lancaster Resources LiDAR Results and Field Trip Data from Lake Cargelligo Gold Project
-
Dynacor Begins Plant Shipments to Senegal; Continues Ecuador Integration
-
Knight Therapeutics Announces Approval and Launch of MINJUVI® (tafasitamab) in Argentina
-
DT Midstream Reports Strong Third Quarter 2025 Results; Raises Adjusted EBITDA Guidance
-
Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
-
Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call
-
FG Nexus Announces Listing on Deutsche Börse in Germany U.S. NASDAQ Ticker is FGNX and German Borse Ticker is LU51
-
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
-
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
-
Digi Power X to Announce 2025 Q3 Financial Results on November 13th
-
Laureate Education Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2025
-
Brixton Metals Makes Copper-Gold Porphyry Discovery at the Catalyst Target on its Thorn Project
-
Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches
-
SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results
-
Saia Reports Third Quarter Results
-
Applied Materials to Report Fourth Quarter and Fiscal 2025 Results on Nov. 13, 2025
-
Epicured Appoints Industry Veteran Patricia Bradley to Oversee Life Sciences Business
-
FreshBooks and Stride Expand Health Benefits Access for U.S. Small Businesses
-
Form 8.3 - AXA INVESTMENT MANAGERS: PRS REIT Plc
-
BULGOLD Commences Drilling on the Lutila Gold Project
-
Celestica Announces TSX Acceptance of Normal Course Issuer Bid
-
HII Reports Third Quarter 2025 Results
-
Iceland Seafood International hf: Q3 2025 results and investors presentation
-
Quantum Solutions Becomes Asia’s Largest Institutional ETH Holder with Backing from ARK Invest’s Cathie Wood
-
Onex Announces Transformational Investment and New Strategic Relationship to Drive Enterprise Growth and Shareholder Value
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidn
-
Zhihu Inc. to Report Third Quarter 2025 Financial Results on November 25, 2025
-
Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
PST Group to Build Rheinmetall Factory in Baisogala
-
Man Group PLC : Form 8.3 - Spectris plc
-
MADD Canada Kicks Off 38th Project Red Ribbon National Campaign to Prevent Impaired Driving this Holiday Season
-
Halcones Precious Metals Announces Commencement of Legal Process to Secure Surface Access to Polaris Project, Chile
-
Studio City Announces Earnings Release Date
-
Trifork Group: Completion of 51.0% divestment of Trifork Security

